Novo Nordisk plans $2.6bn pharma build with engineering partner NNE

6-Jan-2022

NNE is Novo Nordisk's engineering partner from design to construction of this huge expansion and has already delivered the conceptual and basic design for the expansion of the Kalundborg site

Novo Nordisk CEO, Lars Fruergaard Jørgensen and Minister of Industry, Business and Financial Affairs, Simon Kollerup, take a tour in the virtual facility created by NNE in connection with the groundbreaking ceremony for the project

Novo Nordisk has announced its plans to invest more than DKK 17 bn ($2.6bn) in construction of three new manufacturing facilities as well as expansion of one existing facility at the production site in Kalundborg. NNE is Novo Nordisk engineering partner from design to construction of this huge expansion, which signifies one of the largest projects in NNE history.

Novo Nordisk's investment will establish additional capacity across the entire global value chain from manufacturing of active pharmaceutical ingredients (API) to assembly and packaging, with the vast majority being invested in API capacity. These expansions will provide capacity for the production of Novo Nordisk's current and future oral and injectable products. The new facilities will be automated and include state-of-the-art production technologies.

NNE has delivered the conceptual and basic design for the expansion of the Kalundborg site and will continue to act as Novo Nordisk's engineering partner for the coming phases.

Record breaker

CEO of NNE, Jesper Kløve, is proud that Novo Nordisk has chosen NNE as it's engineering partner from design to construction, he said:"I would like to thank Novo Nordisk for entrusting NNE with the execution of this fantastic project, which is one of the biggest we have executed in NNE history. We will do our utmost to live up to all parameters."

Kløve explains that in the design, NNE have strived to take account of many different aspects. First and foremost, the company wanted to design facilities which are future-proof in terms of current and future demands for pharmaceutical production and filled with the latest technology. At the same time, NNE's focus has been to create an interior that ensures good working conditions in terms of space, flow and light for the employees who will spend their workdays inside the facilities.

"Moreover, we have strived to achieve an architectural expression where the buildings look modern, but without drawing too much attention. One of the facilities had to fit in with the existing buildings, while another - the first large building to be established north of the railway - had to fit in with fields, railway and green surroundings," Kløve added. "We have done our absolute best and the future will tell if we achieved what we set out to do."

Applying virtual reality in all project phases

NNE has been involved in the project from the early design phases and has from the beginning focused on using digital tools to support project execution and decision processes.

Based on the digital 3D design model created for the project, NNE has created a collaborative tool based on virtual reality (VR), which allows several users to meet virtually inside the 3D design model and together perform design reviews and make decisions - regardless of where the participants are located physically.

Sign up for your free email newsletter

In the coming construction phase, NNE will apply augmented reality (AR) technology, which makes it possible to review the design model onsite through an iPad or smartphone by adding a digital layer of information on top of reality. This makes it possible to identify and solve challenges on the spot by simply comparing the digital design model against the real-world design.

Companies